Victor Sandor
Net worth: 478 332 $ as of 2026-05-30
Net worth: 478 332 $ as of 2026-05-30
Dr. Victor Sandor, MD, is an Independent Director at AbCellera Biologics, Inc., an Independent Director at Kymera Therapeutics, Inc., an Independent Director at Prelude Therapeutics, Inc. and an Independent Non-Executive Director at ADC Therapeutics SA. He is on the Board of Directors at AbCellera Biologics, Inc., Kymera Therapeutics, Inc., Prelude Therapeutics, Inc., ADC Therapeutics SA and Istari Oncology, Inc. Dr. Sandor was previously employed as an Independent Non-Executive Director by Merus NV, a Chief Medical Officer by Array BioPharma, Inc., a Chief Medical Officer-Oncology & VP by Biogen Idec, Inc. (North Carolina), a Senior VP-Drug Development by Incyte Corp., and a Head-Oncology Product Development by AstraZeneca, Inc. He received his doctorate degree from McGill University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 0.11% | 2026-06-02 | 140,686 ( 0.11% ) | 478 332 $ | 2026-05-30 |
| 2026-06-08 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-06-23 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ADC THERAPEUTICS SA | Director/Board Member | 2020-04-26 |
| PRELUDE THERAPEUTICS INCORPORATED | Director/Board Member | 2020-04-30 |
| KYMERA THERAPEUTICS, INC. | Director/Board Member | 2022-11-02 |
| ABCELLERA BIOLOGICS INC. | Director/Board Member | 2026-05-31 |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Director/Board Member | 2019-06-30 |
| Companies | Position | End |
|---|---|---|
| MERUS N.V. | Director/Board Member | 2025-12-11 |
| INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 2019-08-31 |
| ARRAY TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2019-07-31 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 2014-08-31 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
AbCellera Biologics, Inc.
AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Prelude Therapeutics, Inc.
Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Select your edition
All financial news and data tailored to specific country editions